Chart-Typ:
Zeitraum:
| Intel Unveils New Innovations To Address Customers' Chip-to-systems-level AI Needs | SANTA CLARA (dpa-AFX) - Intel (INTC) unveiled new innovations that address customers' chip-to-systems-level AI needs with solutions tailored to address their specific industry challenges, including:... ► Artikel lesen |
| Phison Electronics: Phison Collaborates with Intel to Bring Larger Local AI Workloads to Intel AI PC Platforms | Phison's Pascari aiDAPTIV removes local memory constraints on client PCs, enabling larger MoE AI models and agentic AI applications
COMPUTEX Phison Electronics (8299TT), a global leader in NAND... ► Artikel lesen |
| ROUNDUP/Aktien New York Schluss: Rekorde zwischen KI-Euphorie und Iran-Skepsis | NEW YORK (dpa-AFX) - Getrieben vom Boom-Thema KI haben die US-Indizes am Montag nach und nach an ihre Rekordserie angeknüpft. Zuerst war es der Leitindex Dow Jones Industrial, der eine Bestmarke erreichte.... ► Artikel lesen |
| Während Merck, Amgen, Novo Nordisk und Fresenius Milliarden bewegen, wächst die Fantasie im Zelltherapie-Sektor | Anzeige / Werbung
Der Biotech-Sektor beginnt sich spürbar zu verändern. Während
Anleger monatelang fast ausschließlich auf KI-Aktien und Halbleiterwerte blickten, fließt inzwischen wieder deutlich... ► Artikel lesen |
| Gilead Gets Positive CHMP Opinion For Trodelvy In First-Line Metastatic TNBC | FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization for Trodelvy... ► Artikel lesen |
| Gilead Sciences, Inc.: Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio | - Acquisition Builds on Gilead's Leadership in Oncology with Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the... ► Artikel lesen |
| Moderna, Inc.: Moderna to Present at Upcoming Conference in June 2026 | CAMBRIDGE, MA / ACCESS Newswire / June 2, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:Goldman Sachs 47th Annual Global Healthcare... ► Artikel lesen |
| Moderna, Inc.: Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting | At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of recurrence... ► Artikel lesen |
| Moderna, Inc.: Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus | Coalition for Epidemic Preparedness Innovations funding builds on Moderna's prior filovirus research and supports preclinical development and Phase 1 clinical evaluation CAMBRIDGE, MA / ACCESS Newswire... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IDL DIAGNOSTICS AB finden Sie auf Wallstreet Online.